Tumor-APC Fusion Technology

  • Check with publisher
  • Published date: December 26, 2018
    • Shirley, New York, United States

A novel development in cancer vaccines is the use of tumor-APC fusion technology. Fusions of tumor cells and antigen presenting cells have been investigated in animal models and clinical trials as candidate cancer vaccines. Creative Biolabs is a world leader in the field of cancer vaccine development. We provide tumor-APC fusion technology platforms to assist you with the development of cancer vaccine.

Fusion of tumor cells to professional APCs in vitro can produce fusion hybrid cells expressing the relevant TAAs and have the ability to process these antigens and present to the immune system to induce efficient tumor specific immunity. Tumor-APC Fusion Cell is, therefore, an attractive candidate for cancer immunotherapy because they express a variety of tumor antigens, process them through the MHC class I and class II pathways and present the processed antigens to the host immune system in the context of effective T-cell co-stimulation.

Result 0 votes
Jerry Carter
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Thyroid Cancer Vaccines

    Thyroid Cancer Vaccines

    Biology & Physiology Shirley (New York) November 30, 2018 Check with publisher

    Creative Biolabs is a world leader in the field of cancer vaccine development. With our extensive experience and advanced platform, we are therefore confident in offering the best services for vaccine development against thyroid cancer and guarantee ...

  • Human AGXT blocking peptide

    Human AGXT blocking peptide

    Biology & Physiology Shirley (New York) November 23, 2018 Check with publisher

    This gene is expressed only in the liver and the encoded protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. Mutations in this gene, some of which alter subcellular targetting, have been associated with ...

  • AGAP1  peptide

    AGAP1 peptide

    Biology & Physiology Shirley (New York) November 23, 2018 Check with publisher

    This gene encodes a member of an ADP-ribosylation factor GTPase-activating protein family involved in membrane trafficking and cytoskeleton dynamics. This gene functions as a direct regulator of the adaptor-related protein complex 3 on endosomes. Mul...